i had/ have similar concerns
Have you had a look at the profiles of other well used IV ABs?
I did some research in MIMs as to plasma half lives, excretion times etc of vancomycin, merepenum, cefazolin, ceftriaxone as these are commonly used ABs in my role and the results were not horrible in comparison
still monitoring the situation but not as alarmed as i was at first
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections, page-15
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
0.035(6.54%) |
Mkt cap ! $116.2M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 57.0¢ | 53.0¢ | $123.1K | 222.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 14635 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |